Live Quote · NASDAQTSHAHealthcare· Biotechnology

Taysha Gene Therapies, Inc.

$3.72▼ 1.33%($-0.05)
MKT CAP $1.21BNEXT EARNINGS Mar 18, 2027
50%
Bullish
TickerSpark Score
57/100
▌ Mixed
55
Valuation
40
Profitability
75
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSHA research report →

Analyst Price Target
$14.00+276.3% vs. today

Range $13 – $15

Analyst RatingBuy
15 Buy3 Hold0 Sell

Price Chart

-6.77% · this period
$6.98$5.25$3.51Nov 20May 26Nov 20
52-Week Range7% of range
Low
$3.46
Current
$3.72
High
$7.30